Genzyme, sanofi trade fresh barbs

Genzyme Corp. (NASDAQ:GENZ) reiterated late Monday that the $69 per share takeover bid from sanofi-aventis Group (Euronext:SAN; NYSE:SNY) is inadequate after the pharma issued a letter in the morning ...